Mechanical Thrombectomy in Ischemic Stroke Patients With Alberta Stroke Program Early Computed Tomography Score 0-5. by Kaesmacher, J. et al.
880
Whether mechanical thrombectomy is beneficial in is-chemic stroke patients presenting with low ASPECTS 
(Alberta Stroke Program Early CT Score) remains uncertain, 
because only a few of these patients were enrolled in the recent 
pivotal thrombectomy trials.1,2 Correspondingly, the current 
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guidelines do not include an unambiguous recommendation 
to treat patients with ASPECTS 0–5, but rather state that me-
chanical thrombectomy may be considered in these patients.3 
Patients with low ASPECTS are at higher risk of symptomatic 
intracerebral hemorrhage (sICH)4–7 and the proportion of sal-
vageable tissue is small, which explains the overall low rate of 
good functional outcomes in this subgroup.1
Previous studies suggested that successful reperfu-
sion may be beneficial to patients with diffusion-weighted 
ASPECTS 0–5 or 0–6, respectively.8–10 The aim of the pre-
sent study was to analyze the effect of successful reperfu-
sion on functional outcome, mortality and sICH in patients 
presenting with ASPECTS 0–5 who were included in the 
Bernese-European Registry for ischemic stroke patients 
treated Outside current guidelines with Neurothrombectomy 
Devices using the SOLITAIRE FR With the Intention For 
Thrombectomy (BEYOND-SWIFT) registry. Furthermore, 
safety and efficacy of endovascular treatment in this sub-
group was assessed in comparison to a group of patients pre-
senting with ASPECTS 6–10.
Methods
BEYOND-SWIFT Registry
BEYOND-SWIFT was a retrospective, international, multicenter ob-
servational registry. The participating centers contributed records of 
consecutive acute ischemic stroke patients, who were treated with a 
CE-labeled market-release neurothrombectomy device manufactured 
by Medtronic (Dublin, Ireland). Further information on the registry 
and participating centers can be found in Information I and Table I in 
the online-only Data Supplement.
The centers provided 2047 patient datasets, of whom 1 missed 
baseline characteristics such as age, sex, and admission National 
Institutes of Health Stroke Scale (NIHSS). Consequently, a total 
of 2046 patients were included into the registry. Most patients in-
cluded in the BEYOND-SWIFT registry were treated for large-vessel 
occlusion (intracranial ICA, M1, and M2) anterior circulation strokes 
(n=1820). Of these, 1630 had documented 90-day follow-up including 
1532 with records of preinterventional ASPECTS. Two-hundred-
thirty-seven patients presented with ASPECTS 0–5 (Figure 1 for 
study flowchart). Data gathered within the framework of this registry 
will be made available for replication or further collaboration on re-
quest to Prof. Dr Urs Fischer and after clearance by the local ethics 
committee in Bern.
Variables and Image Analysis
The site of occlusion was categorized into intracranial internal ca-
rotid artery, carotid-T/L, M1, M2, and M3 segments of the middle 
cerebral artery, A1 and A2 segment of the anterior cerebral artery, 
vertebral artery, basilar artery, P1 and P2 segment of the posterior ce-
rebral artery based on the diagnostic admission imaging (computed 
tomography angiography/magnetic resonance angiography). For 
7 patients, no data on occlusion site was provided. Postprocedural 
Thrombolysis in Cerebral Infarction (mTICI) scale was operator 
adjudicated at each center or rated by an independent research fel-
low, depending on the applicable institutional standards (Table I in 
the online-only Data Supplement). TICI 2b was rated as reperfusion 
of at least 50% of the initially occluded target territory, according to 
the modified version of the TICI scale.11 ASPECTS was evaluated 
at each site (Table I in the online-only Data Supplement) and was 
based on admission CT in 910/1532 cases of anterior large-vessel 
occlusion. In 600 cases, ASPECTS was rated on diffusion-weighted 
magnetic resonance imaging, and in 22 cases, no information on 
the admission imaging modality was provided. Functional clinical 
outcome was evaluated using the modified Rankin Scale (mRS) at 
90 days, which was evaluated by a physician or a trained and certi-
fied mRS nurse usually not involved into acute treatment of the pa-
tient (Table I in the online-only Data Supplement). All participating 
centers evaluated the mRS on routinely scheduled and standardized 
telephone interviews or clinical visits. Neurological symptoms on 
admission and 24 hour after the intervention were evaluated by a 
stroke neurologist applying the NIHSS.
Statistical Analysis
For the present analysis, a protocol with predefined outcome variables 
was written before analysis or inspection of the data began (https://
clinicaltrials.gov/ProvidedDocs/64/NCT03496064/SAP_000.pdf). 
The primary end point of this analysis was mRS score 0–3 (favorable 
outcome) at day 90.12 Secondary and safety outcomes consisted of 
mRS score 0–2 (functional independence) at day 90, major early neu-
rological improvement (defined as admission NIHSS—24h NIHSS 
≥8 or 24h NIHSS <1),13 all-cause mortality at day 90, and sICH.
Univariate comparisons were made using standard statistical 
measures (Fisher exact test for categorical variables, Mann–Whitney 
U test for nonnormally continuous, or ordinally scaled variables 
and Welsch t test for normally distributed data). Association of suc-
cessful reperfusion with all outcome parameters was assessed using 
multivariable logistic regression adjusting for the following prespec-
ified confounders: age, sex, NIHSS on admission, tandem versus 
nontandem (tandem defined as >90% cervical stenosis or cervical 
occlusion), center (categorical, contrast type: indicator, comparator: 
largest center), ASPECTS ≤3 versus ASPECTS 4–5, intravenous 
thrombolysis, risk factor hypertension, dyslipidemia, smoking, pre-
vious stroke, diabetes mellitus, in-hospital stroke, type of admission 
imaging, intracranial ICA/carotid-T versus M1/M2. For sensitivity 
purposes, analyses were rerun either with confinement to a cohort 
presenting with ASPECTS 0–4 or with implementation of the fol-
lowing interaction terms:
1. Successful reperfusion (1: successful) * admission modality (1: 
CT).
2. Successful reperfusion (1: successful) * age ≤70 years versus 
>70 years (1: age≤70).
In a final sensitivity analysis, diffusion-weighted imaging (DWI) 
ASPECTS were increased by 1 point to estimate corresponding 
CT-ASPECTS as suggested by findings derived from the SAMURAI 
registry.6 Thereafter, the population of ASPECTS 0–5 was 
recalculated and analyses were rerun. This analysis was added to the 
statistical analysis plan after protocol finalization and data inspection.
Results
Of 1532 patients included into the present analysis, 237 
patients presented with ASPECTS 0–5, whereas 1295 patients 
had an ASPECTS >5. Distribution of ASPECTS by admission 
imaging modality is shown in Figure IA in the online-only 
Data Supplement.
Study Cohort ASPECTS 0–5
Mean age of patients presenting with ASPECTS 0–5 (N=237), 
was 67.1±14.4 years and 43.5% (N=103) were female. Of 
these 237 patients, 93 presented with ASPECTS 5, 60 with 
ASPECTS 4, and 84 with ASPECTS 0–3. ASPECTS distribu-
tion by imaging modality within the subcohort of ASPECTS 
0–5 is shown in Figure IB in the online-only Data Supplement. 
Patients presented with severe neurological deficits (median 
NIHSS 18; interquartile range [IQR] 15–22) and were admitted 
to the hospital with a median delay from symptom-onset/last-
seen-well to admission of 173 minutes (IQR, 85–278 minutes; 
available for N=190). Successful reperfusion was achieved 
in 69.9% (N=165/236, 1 patient had missing information on 
reperfusions status) patients, with a median groin-puncture to 
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TICI 2b interval of 48 minutes (IQR, 30–79; N=164). Overall 
rates of favorable outcome (mRS ≤3) and mortality at day 90 
were 40.1% (N=95/237) and 40.9% (N=97/237). Early neu-
rological improvement was observed in 21.2% (N=32) of 151 
patients for whom 24 hours NIHSS was available. When com-
paring ASPECTS 0–5 patients with (study population, N=237) 
and without available follow-up (N=13), no systemic bias re-
garding the distribution of baseline characteristics could be 
noted (Table II in the online-only Data Supplement).
Reperfusion in Patients With ASPECTS 0–5
Within the cohort of patients presenting with ASPECTS 0–5, 
there was no difference in baseline characteristics, type of 
admission imaging, occlusion site, or stroke causes between 
successfully and unsuccessfully reperfused patients (P>0.05; 
Table 1). However, univariate comparison revealed a signifi-
cantly superior outcome for successfully reperfused patients, 
as evidenced by all outcome variables (Table 1, Figure 2A, 
and Figure III in the online-only Data Supplement). The 
outcome difference was seen among patients selected by 
non-contrast CT (NCCT) and magnetic resonance imaging, 
although generally, patients selected by magnetic resonance 
imaging had better outcome profiles (Figure 2B). The effect 
was observable in patients with ASPECTS 5 and in patients 
with ASPECTS 4, but not in patients with ASPECTS 0–3 
(Figure IV in the online-only Data Supplement). However, 
a tendency for a mortality reducing effect of successful re-
perfusion in ASPECTS 0–3 was found (47.4% versus 66.7%; 
P=0.108). After adjusting for the prespecified clinical con-
founders listed in the methods section, successful reperfusion 
was associated with favorable clinical outcome (mRS score, 
0–3; aOR, 5.534; 95% CI, 2.363–12.961; Table 2, Figure V 
in the online-only Data Supplement), functional indepen-
dence (mRS score, 0–2; aOR, 5.583; 95% CI, 1.964–15.873), 
major early neurological improvement (aOR, 11.635; 95% 
CI, 3.980–34.011), and reduced mortality (aOR, 0.180; 95% 
CI; 0.083–0.390). Furthermore, rates of sICH were lower in 
successfully reperfused patients (aOR, 0.235; 95% CI, 0.062–
0.887). There was no interaction between type of imaging or 
age groups and effect of successful reperfusion in any of the 
above-mentioned analyses (Table 2). Results of the logistic 
regression output by strata of admission imaging modality are 
shown in Figure VI in the online-only Data Supplement. A sig-
nificant effect of reperfusion was still observed for mRS score 
0–3 and mortality in both subgroups, however, uncertainty 
increased considerably (especially for CT). In a subcohort 
of patients with successful reperfusion, achieving TICI 3 in-
stead of only TICI 2b was found to result in additional benefit 
(Figure IV in the online-only Data Supplement). When analy-
ses were confined to patients with ASPECTS 0–4 (N=144), 
the positive association between successful reperfusion and 
the outcome variables remained statistically significant only 
for mortality (aOR, 0.168; 95% CI, 0.056–0.499; Table 3 and 
Figure VII in the online-only Data Supplement). In a final sen-
sitivity analyses, DWI-ASPECTS was increased by 1 point 
to estimate corresponding NCCT-ASPECTS and transfera-
bility to CT imaging in line with the findings observed in the 
SAMURAI registry (Stroke Acute Management With Urgent 
Risk-Factor Assessment and Improvement).6 Analyses were 
rerun with N=172 patients with adjusted ASPECTS ≤5. Here, 
comparable results were obtained, except that the association 
between successful reperfusion and lower rates of sICH was 
nonsignificant (Table III and Figure VIII in the online-only 
Data Supplement).
Figure 1. Registry flowchart. ASPECTS indicates Alberta Stroke Program Early CT Score; BEYOND-SWIFT, Bernese-European Registry for Ischemic Stroke 
Patients Treated Outside Current Guidelines With Neurothrombectomy Devices Using the SOLITAIRE FR With the Intention for Thrombectomy; LVO, large-
vessel occlusion; and TICI, Thrombolysis in Cerebral Infarction. *One patient was excluded from the comparison of TICI 0-2a with TICI 2b/3 because of miss-
ing data regarding the final reperfusion success.
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Procedural Efficacy, Safety, Complications, and  
Outcome Compared With Patients With  
ASPECTS 6–10
A comparison of baseline characteristics of patients with 
ASPECTS 0–5 versus patients with ASPECTS 6–10 indicated 
that patients treated with ASPECTS 0–5 were younger, more 
often had proximal occlusion patterns and more commonly 
presented with underlying cervical artery dissection (Table 
VI in the online-only Data Supplement). Patients presenting 
with ASPECTS 0–5 had lower rates of successful reperfusion 
(69.9% versus 83.9%; P<0.001) and time from groin punc-
ture to reperfusion was longer (median, 53 minutes; IQR, 
33–85 minutes versus median 45 minutes; IQR, 30–74 min-
utes; P=0.009). Median number of maneuvers did not differ 
between the 2 groups (median, 2; IQR, 1–3 versus 2; IQR, 
1–3; P=0.298; data available for N=1087). Relative frequency 
of TICI 3 was comparable (49.7% versus 55.2%; P=0.208) 
in patients in whom reperfusion was successful (TICI ≥2b, 
Table 1. Comparison of Patients Presenting With ASPECTS 0–5 With and Without Successful Reperfusion
ASPECTS 0–5, N=237* TICI 0-2a (N=71) TICI 2b/3 (N=165) P Value
Age 68.6±13.5 66.4±14.8 0.266
Sex, female 53.5% (38/71) 38.8% (64/165) 0.045
Admission NIHSS 19 (15–22, N=70) 18 (15–22, N=163) 0.636
In-Hospital Stroke 0% (0/71) 1.8% (3/165) 0.556
Symptom-onset/last-seen well to admission 180 (99–281, N=53) 170 (277–77, N=136) 0.274
Admission Imaging, MRI (N=231) 65.7% (46/70) 66.5% (107/161) >0.999
IVT 36.6% (26/71) 47.3% (78/165) 0.153
Risk factors
  Smoking (N=233) 22.5% (16/71) 31.5% (51/162) 0.208
  Hypertension (N=235) 70.4% (50/71) 63.4% (104/164) 0.370
  Dyslipidemia (N=233) 56.5% (39/69) 55.5% (91/164) >0.999
  Previous CVE (N=234) 21.1% (15/71) 14.1% (23/163) 0.183
Occlusion site 0.373
  iICA 2.8% (2/71) 7.9% (13/165)  
  Carotid-T/L 32.4% (23/71) 30.3% (50/165)  
  M1 63.4% (45/71) 58.2% (96/165)  
  M2 1.4% (1/71) 3.6% (6/165)  
Tandem 16.9% (12/71) 18.2% (30/165) 0.855
Underlying cervical dissection 9.9% (7/71) 5.5% (9/164) 0.261
TOAST (N=233) 0.899
  Large-artery 12.9% (9/70) 12.9% (21/163)  
  Cardioembolism 30.0% (21/70) 35.0% (57/163)  
  Other determined cause 8.6% (6/70) 8.0% (13/163)  
  Unknown 48.6% (34/70) 44.2% (72/163)  
Outcome
mRS score 0–3 13.7% (13/71) 49.7% (82/165) <0.001†
mRS score 0–2 11.7% (7/71) 32.1% (51/165) <0.001†
Delta NIHSS 0 (−10 to 2) 3 (0–8) <0.001†
Major early neurological improvement (N=151) 4.8% (2/42) 27.5% (30/109) 0.002†
Mortality 63.4% (45/71) 30.9% (51/165) <0.001†
sICH (N=236) 11.4% (8/70) 5.5% (9/165) 0.165
Data is displayed as mean±SD or median (interquartile range). ASPECTS indicates Alberta Stroke Program Early CT 
Score; Carotid-T/L, T- or L-type occlusion of the carotid terminus; CVE, cerebrovascular event; iICA, intracranial internal 
carotid artery; M1, first segment of the middle cerebral artery; M2, second segment of the middle cerebral artery; MRI, 
magnetic resonance imaging; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; sICH, 
symptomatic intracerebral hemorrhage; TOAST, Trial of ORG 10172 in Acute Stroke Treatment.
*For 1 patient, final reperfusion success was not available.
†P<0.001.
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N=1252). Peri-interventional complications tended to occur 
more frequently in patients with ASPECTS 0–5 (16.9% versus 
12.2%; P=0.058), but no specific type of complication was more 
likely (Table V in the online-only Data Supplement). Rates 
of sICH were comparable between patients with ASPECTS 
0–5 and ASPECTS 6–10 (7.2% versus 6.0%; P=0.466). 
Patients with ASPECTS 0–5 had significantly lower rates of 
favourable outcome (mRS score, 0–3; 40.1% versus 61.2%; 
P<0.001, Figure IX in the online-only Data Supplement) and 
a doubled mortality (40.9% versus 21.2%; P<0.001) com-
pared with those with ASPECTS 6–10. However, the relative 
merits of achieving successful reperfusion was comparable, 
as indicated by comparable adjusted Odds Ratios (Figure 3). 
No evidence for an interaction between successful reperfusion 
Figure 2. Modified Rankin Scale (mRS) of patients with ASPECTS 0–5 (Alberta Stroke Program Early CT Score; N=237) stratified according to reperfusion 
success. A, Mortality was shifted towards higher rates of mRS score 0–3, rather than increasing mRS score 4–5. Shift was significant for mRS score 0–3 
(49.7% vs 13.7%; P<0.001) and mortality (30.9% vs 63.4%; P<0.001). One patient was not included owning to missing data regarding the postinterventional 
reperfusion quality (N=1/237). B, Favorable outcome was more often observed in patients selected by magnetic resonance imaging (MRI) diffusion-weighted 
imaging (DWI-ASPECTS) than in patients selected by CT (45.5% vs. 26.9%; P=0.007). Furthermore, moratlity was higher in patients selected by CT (51.3% 
vs 37.0%; P=0.048). In both, MRI and computed tomography (CT)-selected patients, however, there was a significant increase in patients achieving mRS 
score 0–3 (MRI, 55.1% vs 23.9%, P<0.001; CT, 35.2% vs 8.3%, P=0.014, for reperfused vs nonreperfused, respectively) and decreased mortality among suc-
cessful reperfused patients (MRI, 28.0% vs 56.5%, P=0.001; CT, 38.9% vs 79.2%, P=0.001, for reperfused vs nonreperfused, respectively).
Table 2. Output of Logistic Regression Model After Adjustment for Confounders (ASPECTS 0–5)
ASPECTS 0–5 N=237
N Included Into 
Regression aOR TICI 2b/3 95% CI P Value
P Value for 
Interaction With Age 
(≤70 vs >70)
P Value for 
Interaction With MRI 
vs CT
Primary
mRS score 0–3 221/237 5.534 2.363–12.961 <0.001 0.125 0.580
Secondary
mRS score 0–2 221/237 5.583 1.964–15.873 0.001* 0.891 0.998
sICH 220/237 0.235 0.062–0.887 0.033† 0.181 0.690
Mortality 221/237 0.180 0.083–0.390 <0.001* 0.332 0.662
Major early neurological 
improvement
144/237 6.627 1.361–32.276 0.019† 0.063 0.998
aOR indicates adjusted odds ratio; ASPECTS, Alberta Stroke Program Early CT Score; CT, computed tomography; MRI; magnetic resonance imaging; 
mRS, modified Rankin Scale; and sICH, symptomatic intracerebral hemorrhage.
*P<0.01.
†P<0.05.
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and ASPECTS 0–5 versus ASPECTS 6–10 was observed for 
all outcomes (Figure 3).
Discussion
Whether ischemic stroke patients presenting with low 
ASPECTS should be treated with mechanical thrombectomy 
is currently one of the most relevant unanswered question in 
acute stroke treatment. There were 4 major findings in our ret-
rospective subgroup analysis derived from a large multicenter 
retrospective registry: (1) In patients with ASPECTS 0–5, suc-
cessful reperfusion—at best TICI 314,15—showed a robust as-
sociation with better functional outcome, lower mortality and 
fewer sICH. (2) These effects remained significant after adjust-
ing for imaging modality-associated variance, but were less 
marked in patients presenting with ASPECTS 0–4, where only 
the effect on mortality remained significant. (3) As anticipated, 
patients with ASPECTS 0–5 had a significantly worse clinical 
course than patients with ASPECTS 6–10. (4) Interventions 
led to less successful reperfusion and tended to be more com-
plicated in patients with ASPECTS 0–5 than in patients with 
ASPECTS 6–10, but rates of sICH were comparable.
In our multicenter registry, 15.5% (237/1532) of patients 
with endovascularly treated large-vessel occlusion anterior 
circulation strokes presented with ASPECTS 0–5. The propor-
tion of patients treated with low ASPECTS scores differed sig-
nificantly between participating centers, supporting the notion 
that treatment decisions regarding this subgroup vary widely. 
Only ≈10% of patients included in the HERMES collaborative 
Table 3. Output of Logistic Regression Model After Adjustment for Confounders (ASPECTS 0–4)
ASPECTS 0–4 N=144
N Included Into 
Regression aOR TICI 2b/3 95% CI P Value
P Value for 
Interaction With Age 
(≤70 vs >70)
P Value for 
Interaction With MRI 
vs CT
Primary
mRS score 0–3 133/144 2.589 0.858–7.816 0.091 0.140 0.998
Secondary
mRS score 0–2 133/144 3.971 0.951–16.585 0.059 0.958 0.998
sICH 132/144 0.285 0.053–1.541 0.145 0.164 0.773
Mortality 133/144 0.168 0.056–0.499 0.001* 0.346 0.998
Major early neurological 
improvement
89/144 11.621 0.760–177.690 0.078 0.071 0.999
aOR indicates adjusted odds ratio; ASPECTS, Alberta Stroke Program Early CT Score; CT, computed tomography; MRI; magnetic resonance imaging; 
mRS, modified Rankin Scale; and sICH, symptomatic intracerebral hemorrhage.
*P<0.01.
Figure 3. Effect of successful reperfusion in patients with ASPECTS 0–5 (Alberta Stroke Program Early CT Score) and patients with ASPECTS 6–10. Adjusted 
odds ratios were calculated in both subgroups using multivariable binary logistic regression adjusting for age, sex, admission National Institutes of Health 
Stroke Scale (NIHSS), tandem lesion, center, intravenous thrombolysis, risk factor hypertension, risk factor dyslipidemia, risk factor smoking, risk factor 
previous stroke, risk factor diabetes mellitus, in-hospital stroke, type of admission imaging, intracranial ICA/carotid-T vs M1/M2. Interaction was tested re-
peating the analysis in all patients and implementing an interaction term ASPECTS 0–5 vs ASPECTS 6–10 * TICI 2b/3. Please note that for ASPECTS 0–5 the 
adjusted odds ratio slightly differ from the analysis in Table 2, because the term ASPECTS 0–3 vs 4–5 was removed.
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analysis presented with ASPECTS 0–5, which may partially 
explain the nonsignificance of the point estimate in this sub-
group (OR, 1.24; 95% CI, 0.62–2.49; n=121).1 Corroborating 
our findings, Mourand et al10 showed that patients with dif-
fusion-weighted ASPECTS 0–5 undergoing endovascular 
thrombectomy had better outcomes than patients who did not 
receive endovascular treatment. Furthermore, another recent 
multicenter analysis found equal rates of sICH, but better 
outcome in the successfully reperfused patient group (mRS 
score, 0–2; adjusted relative risk, 3.00; 95% CI, 1.71–5.29).9 
In the present study, which only included patients with CT or 
diffusion-weighted ASPECTS ≤5, we not only found better 
outcomes in successfully than in unsuccessfully reperfused 
patients but also lower rates of sICH. This observation has 
also been reported by others.16 Hence, some reassurance is 
provided that rates of sICH will not be substantially higher if 
patients are reperfused endovascularly, despite abrupt restora-
tion of blood flow into a large infarct core.
Despite the potential of more favorable results in endovas-
cularly treated patient, the overall proportion of patients with 
functional independence (mRS score, 0–2) at 3 months was 
limited to 25% overall, and 32% when reperfusion occurred. 
Therefore, patients and families should be informed that acute 
treatment in such situations will still be associated with an im-
portant likelihood of dependency or death in the majority of 
patients, and other prognostic factors may be considered be-
fore a treatment decision is made. Interestingly, patients with 
ASPECTS 0–5 had lower recanalization rates despite equal 
number of thrombectomy attempts. A possible explanation 
may arise because of the operator’s decision to stop the pro-
cedure because it was deemed futile in light of the advanced 
ischemic core. However, it should also be considered that 
there were significant differences between ASPECTS 0–5 and 
ASPECTS 6–10 patients regarding occlusion site distribution, 
frequency of underlying cervical artery dissection and stroke 
causes. All of the latter may also effect the occurrence of com-
plications; hence, this observation and its interpretation as 
more complicated procedures should be handled with caution.
There are multiple conceivable reasons for a clinical ben-
efit of successful reperfusion despite low ASPECTS and these 
are in part associated with the limitations of the ASPECTS 
methodology.17 First, ASPECTS is only a mediocre surrogate 
for infarct volume18 and, just like sole infarct volume, neglects 
the eloquence of the respective tissue, with significant differ-
ences being observed across different ASPECTS areas.19–21 
Second, some DWI-ASPECTS lesions may be reversible, 
especially in the first 3 hours after symptom-onset,22,23 thus 
leading to overestimation of the infarct core. However, it 
has been shown that the clinical significance and tissue vol-
umes associated with lesion reversal are minimal.24,25 Third, 
the ASPECTS suggests a merely dichotomized course of is-
chemic lesions (infarcted versus not infarcted), which is likely 
to be not true. Several studies assessed the importance of grad-
ually decreasing ADC values and its intralesional patterns for 
patients’ outcome and risk of hemorrhagic transformation.26,27 
Last and according to the different ischemic tolerance of gray 
and white matter,28–30 both tissue types are likely to undergo 
infarction at different time points. As such, white matter tracts 
in an ASPECTS positive (gray matter largely infarcted) region 
may be salvaged by rapid reperfusion,31–34 thus overestimating 
the infarct core and underestimating the potential beneficial 
effect of successful reperfusion in this area.31
In general, older patients have higher odds for poor out-
come, which is mostly because of more comorbidities and 
decreased functional reserve.35 Corroborating this, age was 
found to be a major predictor in all multivariate logistic re-
gression models applied in the ASPECTS 0–5 subgroup. 
Mourand et al10 suggested that patients aged ≤70 were partic-
ularly likely to benefit from endovascular treatment when pre-
senting with ASPECTS 0–5. We found no evidence, however, 
that the outcome-modifying effect of successful reperfusion 
differed substantially between age groups. We thus conclude 
that limiting endovascular treatment to younger patients with 
ASPECTS 0–5 does not seem to be justified by our data.
The present analysis included both patients with CT 
(N=78) and with diffusion-weighted (N=154) ASPECTS 0–5 
(in 5 patients no information on imaging modality was avail-
able). Although diffusion-weighted ASPECTS is thought to be 
more sensitive in terms of detecting early ischemic changes,6 
it may also overestimate the final infarct core.25,32 In our anal-
ysis, we did not find a significant interaction between the 
effect of successful reperfusion and the imaging modality on 
which the ASPECTS scoring was based. However, patients for 
whom CT was the admission imaging modality had a poorer 
prognosis per se. A sensitivity analysis with implementation 
of a 1-point increase in the diffusion-weighted ASPECTS also 
failed to provide evidence that the above-mentioned associa-
tion between successful reperfusion and better outcome would 
change significantly.
Limitations
Most importantly, ASPECTS scores were rated at each center 
and were not core-lab adjudicated. Hence, there is uncertainty 
because of interrater variability. In particular, this has to be 
kept in mind, as the interrater agreement for DWI-ASPECTS36 
and CT-ASPECTS37 is only modest. Our analysis, however, 
primarily used dichotomizations of ASPECTS 0–5, which 
will decrease the interrater variability to some extent.36 
Furthermore, the low ASPECTS group is primarily supplied 
by 3 centers, limiting generalizability of the findings. Another 
limitation of the ASPECTS is that it fails to account for is-
chemia outside the middle cerebral artery territory, such as 
anterior cerebral artery and posterior cerebral artery infarcts 
in case of carotid-T occlusions. In addition, simply adding 1 
point to DWI ASPECTS may not adequately reflect the differ-
ence between CT and DWI-ASPECTS in our cohort, because 
the SAMURAI registry did not exclusively include large-ves-
sel occlusion patients (22.5% with M2/M3 and 28.3 without 
visible occlusion) and only a few patients with low ASPECTS 
were included, which may alter correlation between CT and 
DWI ASPECTS observed in this study. Furthermore, opera-
tor-graded TICI scoring may lead to further bias (eg, because 
the operator tends to overestimate the success of her or his 
intervention). Third, a lost-to-follow-up rate of 10.1% har-
bors the potential of selection bias. However, lost-to-follow-
up rates were lower in the ASPECTS 0–5 group, than for the 
ASPECTS 6–10 group (5.2% versus 10.9%; P=0.004) and 
we did not detect a systemic bias when comparing baseline 
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parameters of patients with and without follow-up. Fourth, 
only patients treated endovascularly were included in this reg-
istry, which may introduce a selection bias towards patients 
with ASPECTS 0–5, in whom the chances of a good outcome 
were rated decent (according to other clinical factors, not 
corrected for in the multivariate analysis). Last, this analysis 
includes interventions with only 1 device.
In summary and because of the retrospective, nonrandom-
ized nature of the data and the lack of an untreated control 
group, our results should be viewed as hypothesis generating 
that suggest the need of a future randomized controlled trial. 
However, when considering that the outcome for unsuccess-
fully reperfused patients resembles the natural course of the 
disease, and may thus partially substitute for a control group, 
the current analysis supports the notion that rapid and com-
plete reperfusion in these patients is beneficial. This deduc-
tion is limited by the fact that an unsuccessful procedure may 
actually harm the patient by, for example, complications and 
sedation. Hence, formal testing of the best treatment approach 
(ie, mechanical thrombectomy versus best medical treatment) 
in randomized controlled trial is warranted and 1 has recently 
started recruiting patients (TENSION [Efficacy and Safety of 
Thrombectomy in Stroke With Extended Lesion and Extended 
Time Window], Clinical Trial Registration—URL: https://
www.clinicaltrials.gov. Unique identifier: NCT03094715). 
In addition, this study highlights the potential impact of the 
imaging modality used for ASPECTS grading and associated 
outcomes of selected populations. Future trials should aim to 
consider these populations separately and adjust their power 
calculations accordingly. The results support the notions that 
cut-offs for treatment are likely to be not directly comparable 
among centers using CT or magnetic resonance imaging.
Conclusions
In the subgroup of patients presenting with ASPECTS 0–5, 
successful reperfusion is associated with superior out-
comes and a better safety profile compared with patients 
in whom reperfusion was unsuccessful. The mortality re-
ducing effect remained tangible in patients with ASPECTS 
0–4. Rates of sICH were comparable between patients with 
ASPECTS 0–5 and those with ASPECTS 6–10, suggest-
ing that abrupt restoration of blood flow into a large infarct 
after successful reperfusion does not necessarily increase 
the risk of sICH. The data stresses the need for a random-
ized controlled trial comparing the benefits of endovascular 
treatment versus best medical treatment in this subgroup of 
patients. Furthermore, the study underlines that these trials 
should separately assess included populations with strata of 
imaging modality used for selection.
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